Coupon for free nexium

Nexium® 24HR 20mg Mini Capsules provide lasting relief from frequent heartburn and acid reflux in a 53% smaller capsule (based on volume of the capsule vs Nexium® 24HR Once Daily Dosing Tablet)

Nexium 24 Hour Once Daily Dosing provides lasting relief for frequent heartburn & acid reflux.

Boxed Contents: 14 Mini Capsules Size: 14 Mini Capsules

Warnings

Do not use:

  • For children under 18 years of age.
  • If allergic to esomeprazole.
  • If allergic to any other proton pump inhibitor (omeprazole, rabeprazole, lansoprazole, pantoprazole).
  • If you are taking antiretroviral medicines, such as atazanavir.
  • If you are taking cilostazol, a medicine used to treat pain and/or cramping in the lower leg (or arms) due to inadequate blood flow to the muscles.
  • If you are breastfeeding or intend to breastfeed.
  • If the expiry date printed on the pack has passed.
  • Do not use if foil seal is broken.

CAUTION Always read the label. Follow the directions for use.

Ingredients

Each capsule contains Esomeprazole magnesium trihydrate 22.3mg (equivalent to esomeprazole 20mg)

Active Ingredients: Each capsule contains Esomeprazole magnesium trihydrate 22.3mg (equivalent to esomeprazole 20mg)

Directions

Adults 18 years, of age and over: Take 1 capsule daily for at least 7 days and up to 14 days.

Swallow the capsule whole with water, with or without food. Do not crush, chew or open the capsule. Not intended for immediate relief. It may take a few days to achieve maximum results.

Do not take for more than 14 days unless directed by a doctor.

USAGE ADVICE The bottle contains a sealed container with silica gel desiccant. Keep the bottle tightly closed to protect from moisture.

SAFETY DIRECTIONS

Carefully read the enclosed leaflet before use.

Ask your doctor or pharmacist before use if you:

  • Are pregnant or intend to become pregnant,
  • Have or ever have had serious liver disease.
  • Are taking digoxin (a medicine used to treat heart problems.
  • Are taking ketoconazole (a medicine used to treat fungal infections).
  • Are taking clopidogrel or warfarin (medicines used to stop the blood clotting).
  • Are taking other medicines regularly.

STORAGE INSTRUCTIONS Store below 25°C in a cool, dry place. Storage Temperature: Below 25°C.

Read the enclosed leaflet before use. If you are unsure about this medication, talk to your doctor or pharmacist.

Active IngredientsPlease read the enclosed packaging and labels before use.

Details

Nexium Control provides a course of treatment for relieving symptoms of heartburn, indigestion, and acid reflux. Each pack contains 7 tablets intended for short-term use. These tablets work by reducing stomach acid production, thereby managing discomfort associated with digestive acid-related conditions. It's important to follow the instructions provided for optimal results. GlaxoSmithKline (UK) Trading Limited GSK Consumer Healthcare (IE) Ltd., 980 Great West Road, Brentford, TW8 9GS, U. K. Or: 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland.

Show more

Ingredients

Ingredients: Each Gastro-Resistant Tablet contains 20 mg Esomeprazole (as Magnesium Trihydrate). Contains sucrose. See package leaflet for further information. As we are always looking to improve our products, our formulations change from time to time, so please always check the packaging before use.

Directions

Directions for use: Take one tablet once a day. Do not exceed this dose. The tablets should be swallowed whole. Do not chew or crush the tablets. May take 2-3 days for full effect. If your symptoms worsen or do not improve after taking this medicine for 14 days in a row, contact your doctor. Read the package leaflet before use. Oral use. Storage recommendation: Do not store above 30°C. Store in the original package in order to protect from moisture. Keep out of the sight and reach of children.

allall>in

For further information about GlaxoSmithKline (UK) Drugs

For further information about Consumer Healthcare (IE) Ltd.

Pharmaceutical companies have been trying to keep their business from going the extra mile, as the Food and Drug Administration has found.

According to a news release from the Health Sciences Centre, on May 30, a study by the National Institutes of Health (NIH) revealed that more than one-quarter of all cancer deaths are linked to the use of over-the-counter (OTC) versions of the medication Nexium, and it's not clear what the problem is.

The NIH found that the amount of NEXIUM was not as much as was found in the US, and that the drug was not approved for use in Australia, where the drug is sold.

The study also found that the drug was being used in more than 30 countries around the world, including the UK, Australia and Japan.

It is important for people who are taking these medications to know that they're not getting the same benefits as people who do not take them.

In the new study, researchers found that the drugs are having the opposite effect on cancer cells, which are known as malignant cells, in a way that suggests that they cause cancer.

The study, published in the Journal of the American Medical Association (JAMA), was conducted by researchers at the NIH.

The researchers studied cancer cell lines that were taken from a group of women who took the drug and then exposed to various doses of NEXIUM.

Researchers concluded that the drugs were having the opposite effect on cancer cells, meaning that they caused cancer.

The drug was used in more than 30 countries around the world, including the UK, Australia and Japan.

In addition to the drugs, the researchers also found that the cancer cells were not being killed by NEXIUM, and that the cancer cells were becoming more aggressive.

The study also looked at a small group of people.

In this small group of people, NEXIUM was used in at least 10 countries, including the UK, Australia and Japan.

The drug's effect on cancer cells was very similar to that of the cancer cells in the group, according to the researchers.

However, it was important to note that the researchers found that the cells were not dying, and that the cancer cells had grown more aggressive.

This study suggests that the use of NEXIUM in the US, where the drug is sold, might be increasing the chances of cancer returning.

The researchers found that the cancer cells had grown more aggressive, which is what the researchers were concerned about.

The cancer cells in this group were more aggressive, which is what they were concerned about.

The drug was found to be having a different effect on cancer cells that had grown more aggressive, and that the cancer cells in the group were more aggressive.

This study is part of a larger study on cancer, which was conducted at the same time.

The researchers are now working to try and find out what may be causing cancer in the US, Europe and Canada.

The study was published in the Journal of the American Medical Association (JAMA).

The researchers are also interested in a group of people who have taken the drug in the past, including people in Canada.

The researchers also found that the drug had been taken in more than 30 countries, including the UK, Australia and Japan.

The drugs were being taken by people in a similar group as were used in the studies.

A spokesperson for the US Food and Drug Administration said: "These findings are important because the drug is being used for more than 30 years, and the studies have been very limited.

"Our analysis found that the drugs were being taken more than 30 years ago and had been used for more than 10 years.

"This suggests that the use of the drugs is likely to be increasing the chances of cancer returning, and that new research needs to be conducted on these issues."

The Food and Drug Administration has yet to answer questions about the study.The study was conducted by researchers at the NIH. (Image credit: iStock/Getty Images)

The FDA did not comment on the researchers' findings.

The researchers also said that the drug was being used in more than 30 countries around the world, including the UK, Australia and Japan.

They said that the drug has not been approved by the Food and Drug Administration (FDA) for sale in the US, Europe and Canada, where the drug is sold.

Details

Nexium Control provides a course of treatment for relieving symptoms of heartburn, indigestion, and acid reflux. Each pack contains 7 tablets intended for short-term use. These tablets work by reducing stomach acid production, thereby managing discomfort associated with digestive acid-related conditions. It's important to follow the instructions provided for optimal results. GlaxoSmithKline (UK) Trading Limited GSK Consumer Healthcare (IE) Ltd., 980 Great West Road, Brentford, TW8 9GS, U. K. Or: 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland.

Show more

Ingredients

Ingredients: Each Gastro-Resistant Tablet contains 20 mg Esomeprazole (as Magnesium Trihydrate). Contains sucrose. See package leaflet for further information. As we are always looking to improve our products, our formulations change from time to time, so please always check the packaging before use.

Directions

Directions for use: Take one tablet once a day. Do not exceed this dose. The tablets should be swallowed whole. Do not chew or crush the tablets. May take 2-3 days for full effect. If your symptoms worsen or do not improve after taking this medicine for 14 days in a row, contact your doctor. Read the package leaflet before use. Oral use. Storage recommendation: Do not store above 30°C. Store in the original package in order to protect from moisture. Keep out of the sight and reach of children.

ó

This product is a Prescription Only Medicine. This medicine is dispensed by or by pharmacist at the destination’s pharmacy. Pharmacist is trained to dispense prescription only medicines and is also a member of the Pharmacy Guild of Canada. Please note that our customer services are not professional and aim to be fair.

Please note that our customer service is professional and is available on request. If you have any questions please contact the pharmacy you receive, or telephone us via your account, using the ‘Ask for Further Information’ button in our patient information leaflet. As this is a store to be managed by a pharmacist, please inform the pharmacist or customer service on further usage of this medicine.

Nexium Control® 20mg Gastro-Resistant Tablets are specially formulated to treat frequent heartburn and acid reflux so that both, complete! Nexium Control® 20mg Gastro-Resistant Tablets contain esomeprazole 20mg to help you get back on your feet with more confidence. Nexium Control® 20mg Gastro-Resistant Tablets are specially formulated to reduce your acid reflux risk by counteracting the evil taste that fuels frequent heartburn. Nexium Control® 20mg Gastro-Resistant Tablets come in a clinically proven dose and length of action that works only when taken as directed. Nexium Control® 20mg Gastro-Resistant Tablets are formulated to target your acid reflux mechanism with the lowest dose possible.

Product Benefits:

  • Treats frequent heartburn
  • Aids you out of gas with a sense of relief
  • Forfills stomach pain and discomfort equivalent to 4 tablets
  • Take 3 tablets immediately before ‘burn-free’ food
  • Suitable for adults only

Directions for Use:

  • Take 1 tablet a day at least 1 hour before eating a high-fat meal to help ensure optimum absorption.
  • Do not take more than 3 tablets in 24 hours.

SIDE EFFECTS: Headache, dizziness, flushing, nasal congestion, abdominal cramps, insomnia, stuffy nose, diarrhoea, nausea, vomiting, and stomach pain may occur. If any of these effects last or get worse, stop taking Nexium and seek medical help right away.

Do not take Nexium Control® 20mg Gastro-Resistant Tablets if you are allergic to esomeprazole or any of the other ingredients of this medicine.

Do not take Nexium Control® 20mg Gastro-Resistant Tablets if you are allergic to any other ingredients in this medicine.

Inform your doctor if you have any medical conditions, especially: heart problems such as severe heart failure, heart attack or irregular heartbeat; liver disease; or severe allergies. Nexium Control® 20mg Gastro-Resistant Tablets are not safe for children under 8 years old.

Side Effects: Headache, dizziness, stuffy nose, dizziness, upset stomach, skin rash, itching, swelling, muscle aches, diarrhoea, skin rashes, dizziness, and changes in skin structure or vision (e.g. seeing an enlarged powered by the active ingredient esomeprazole) may occur.

This medicine may cause a drop in blood pressure, especially when taken at the start of a heart attack, and may lead to dehydration or dizziness. This is not a complete list of side effects. Visit the or call 1-800-TINGRS as quickly as possible if you are experiencing any side effects. side effects can include: allergic reactions, such as skin rash or hives, that may occur; fainting; constipation; dizziness; drowsiness; nausea; and sexual problems such as ejaculation.

Drug Interactions:

Drug interactions may occur with esomeprazole, itraconazole, ketoconazole, posologyim, and rifampin. If you are taking a medication that increases the risk of blood clots or heart attack, stop taking Nexium and seek medical help right away. Just like any other medication, there may be interactions with other medications. For example, there may be an increased risk of sudden cardiac death with cimetidine.

Storage:

Store at room temperature, away from light and moisture. Keep out of the reach of children.

Frequently Asked Questions

What is Nexium Control® 20mg Gastro-Resistant Tablets areTSCare**?

Nexium Control® 20mg Gastro-Resistant Tablets contain esomeprazole 20mg to treat frequent heartburn.